Peregrine Pharmaceuticals Inc $1.65

down 0.00


29/8/2014 04:00 PM  |  NASDAQ : PPHM  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get PPHM Trend Analysis - it has underperformed the S&P 500 by 2%

Partner Headlines

  1. Earnings Scheduled For July 14, 2014

    Benzinga
  2. Peregrine Pharmaceuticals Announces Investigator-Sponsored Trial Combining ...

    Benzinga
  3. UPDATE: Peregrine Pharma Reports Data on Bavituximab Presented at AACR ...

    Benzinga
  4. Morning Market Movers

    Benzinga
  5. Mid Morning Gainers for March 11th, 2014

    Benzinga
  6. Mid-Afternoon Market Update: 3D Printing Names Take a Hit From Barron's ...

    Benzinga
  7. Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares ...

    Benzinga
  8. Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales ...

    Benzinga
  9. Earnings Scheduled For March 7, 2014

    Benzinga
  10. Morning Market Movers

    Benzinga
  11. Peregrine Pharmaceuticals Initiates Sunrise Pivotal Phase III Clinical ...

    Benzinga
  12. Earnings Scheduled For December 10, 2013

    Benzinga
  13. Peregrine's Bavituximab in Combination With Anti-CTLA-4 Antibodies Yields ...

    Benzinga
  14. Peregrine Pharma Reports Results from Phase 2 Trial of Bavituximab, Says ...

    Benzinga
  15. Peregrine Pharmaceuticals Finds Its Stride Again: Exclusive Interview With ...

    Benzinga
  16. Peregrine Pharmaceuticals Soars 80% on Study Review

    Benzinga
  17. Major Averages Record Small Losses to Start Week

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

    Benzinga
  20. Earnings Scheduled For December 10, 2012

    Benzinga
  21. The Week Ahead: Washington in Focus

    Benzinga
  22. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  23. Peregrine Shares Higher as Co. Reports Significant Progress in Advancing ...

    Benzinga
  24. Benzinga's Microcap Movers for Wednesday October 17, 2012

    Benzinga
  25. Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Peregrine ...

    Benzinga
  26. Benzinga Mid-Day Market Update

    Benzinga
  27. Bronstein, Gewirtz & Grossman Announces Investigation of Peregrine Pharmaceuticals

    Benzinga
  28. Benzinga Mid-Afternoon Market Update

    Benzinga
  29. Mid-Day Market Losers

    Benzinga
  30. Benzinga Mid-Day Market Update

    Benzinga
  31. Morning Market Losers

    Benzinga
  32. Peregrine Pharma Says Discovered Major Discrepancies in Control Group; ...

    Benzinga
  33. Benzinga's Top Pre-Market Gainers

    Benzinga
  34. Earnings Scheduled For September 10, 2012

    Benzinga
  35. Peregrine Pharma Says Phase II Trial Shows Doubling of Survival

    Benzinga
  36. Peregrine Pharmaceuticals Secures $30 Million Loan Facility

    Benzinga
  37. Health Care Sector Wrap

    FoxBusiness
  38. Markwest Energy Partners, Dicks Sporting Goods Among Stocks Down on Above-average ...

    FoxBusiness
  39. Peregrine Pharmaceuticals Soars After Smaller Than Expected Loss

    Benzinga
  40. Peregrine Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  41. Earnings Scheduled For July 16

    Benzinga
  42. Peregrine Pharmaceuticals Continues Strong Momentum; Shares up 14%

    Benzinga
  43. Ultimate Stock Watch List for The Supreme Court's Health Care Ruling

    Benzinga
  44. Avid Bioservices Announces Addition of Novel Bacteriophage

    Benzinga
  45. UPDATE: Peregrine Says Preliminary Data From Phase II Study Shows Antiviral ...

    Benzinga
  46. Peregrine Provides Update on HCV Clinical Program

    Benzinga
  47. Peregrine Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  48. Is This Drug About to Cure Cancer?

    Benzinga
  49. Microcap Movers for Tuesday December 6, 2011

    Benzinga
Trading Center